The World Health Organisation has issued an alert against three "substandard" oral cough syrups identified in India -- Coldrif, Respifresh TR and ReLife -- and urged national regulatory authorities......
In light of recent concerns surrounding potential rare side effects of the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical giant has reiterated its commitment to patient safety while......
Sputnik V is already approved in India and Sinovac is unlikely to come in as it does not meet the criteria, reports Sohini Das. IMAGE: A woman receives a dose of Covishield at a vaccination centre......
The World Health Organisation on Tuesday issued a product alert over contaminated syrup by an Indian manufacturer, warning that it is unsafe for use, especially in children, and may result in......
India's apex drug regulator has waived the requirement of testing every batch of foreign-made COVID-19 vaccines by the Central Drugs Laboratory, Kasauli and post-launch bridging trials for such......
Close on the heels of the Canadian government warning against the use of Indian herbal remedies, Britain's healthcare agency has said herbal remedies available in the country may contain dangerous......
A fresh US executive order (EO) which seeks to bring down prices of prescription drugs in the country by up to 90 per cent -- on par with other developed nations -- will affect innovator companies,......
Law enforcement agents have arrested 237 people worldwide in a 10-day crackdown on fake drugs, resulting in the seizure of counterfeit and unlicensed medicines worth 18.6 million pounds ($31.4......
UK health regulatory authority enforces strict norms for export, in wake of EU directive. Indian ayurvedic medicines manufacturers are set to face a tough time as far as exports to European......
The company’s revenue from the European market is pegged at around euro 160 million. Of this, UK makes up for euro 110 million, followed by Ireland at euro 30 million and rest from France and......